APT070 inhibits complement activation during in vitro cardiopulmonary bypass.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  European Journal of Cardio-Thoracic Surgery

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.EJCTS.2006.03.012PMID 16723247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Soluble Human Complement Receptor 1 Limits Ischemic Damage in Cardiac Surgery Patients at High Risk Requiring Cardiopulmonary Bypass

  2004cited by this paper
• Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit

  2004cited by this paper
• Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.

  2004cited by this paper
• Targeting anticomplement agents.

  2002cited by this paper
• Structure–function relationships of complement receptor type 1

  2001cited by this paper
• Continual Low-Level Activation of the Classical Complement Pathway

  2001cited by this paper
• Membrane-targeted complement inhibitors.

  2001cited by this paper
• Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits.

  2001cited by this paper
• Pathophysiologic role of selectins and their ligands in ischemia reperfusion injury.

  2000cited by this paper
• Complement Activation, Cytokines, and Adhesion Molecules in Children Undergoing Cardiac Surgery with or without Cardiopulmonary Bypass

  1999cited by this paper
• Systemic inflammation induced by cardiopulmonary bypass: a review of pathogenesis and treatment.

  1999cited by this paper
• Structure‐activity relationships within the N‐terminal short consensus repeats (SCR) of human CR1 (C3b / C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation

  1999cited by this paper
• Cell surface engineering using a complement regulatory molecule modified with a synthetic myristoyl-electrostatic switch derivative

  1998cited by this paper
• The Systemic Inflammatory Response to Cardiopulmonary Bypass: Pathophysiological, Therapeutic, and Pharmacological Considerations

  1997cited by this paper
• Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass.

  1995cited by this paper
• Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.

  1995cited by this paper
• Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization.

  1994cited by this paper
• Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass.

  1993cited by this paper
• Humoral and cellular activation in a simulated extracorporeal circuit.

  1993cited by this paper
• Effects of simulated extracorporeal circulation on human leukocyte elastase release, superoxide generation, and procoagulant activity.

  1991cited by this paper
• The effect of body temperature on leukocyte kinetics during cardiopulmonary bypass.

  1985cited by this paper
• Complement and the damaging effects of cardiopulmonary bypass.

  1983cited by this paper
• Complement and the damaging effects of cardiopulmonary bypass.

  1983cited by this paper
• Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.

  1978cited by this paper
• Prevention of acute immunological lung lesion in rats by decomplementing treatment.

  1969cited by this paper

• Research progress on the pathogenesis of AKI complicated by ECMO

  2024cites this paper
• Inflammation and Oxidative Stress in the Context of Extracorporeal Cardiac and Pulmonary Support

  2022cites this paper
• Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition.

  2014cites this paper
• Machine perfusion for assessing and optimizing kidney and pancreas allografts

  2014cites this paper
• New Insights of an Old Defense System: Structure, Function, and Clinical Relevance of the Complement System

  2010influential citation
• New inhibitors of the complement system inspired in K76-COOH. A SAR study of filifolinol derivatives through modifications of the C3' position.

  2009cites this paper
• Background and Purpose Experimental Approach Conclusions and Implications

  year unknowncites this paper